Douglas Reed, FNP-C

NPI: 1457641300
Total Payments
$1,254
2024 Payments
$725.60
Companies
7
Transactions
42
Medicare Patients
966
Medicare Billing
$119,885

Payment Breakdown by Category

Food & Beverage$1,154 (92.0%)
Education$99.99 (8.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,154 41 92.0%
Education $99.99 1 8.0%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $398.12 5 $0 (2024)
Otsuka America Pharmaceutical, Inc. $248.93 11 $0 (2024)
Corium, LLC $205.15 11 $0 (2024)
Lundbeck LLC $147.07 7 $0 (2024)
Neurocrine Biosciences, Inc. $144.87 3 $0 (2023)
ABBVIE INC. $69.23 3 $0 (2024)
ITI, Inc. $40.92 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $725.60 28 Otsuka America Pharmaceutical, Inc. ($248.93)
2023 $411.51 13 Neurocrine Biosciences, Inc. ($144.87)
2021 $117.18 1 Janssen Pharmaceuticals, Inc ($117.18)

All Payment Transactions

42 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.86 General
Category: NEUROSCIENCE
11/21/2024 Lundbeck LLC ABILIFY ASIMTUFII (Drug) Food and Beverage Cash or cash equivalent $16.34 General
Category: PSYCHIATRY
11/01/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $20.50 General
Category: PSYCHIATRY
10/31/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $19.41 General
Category: CNS Stimulant for ADHD
10/23/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $29.94 General
Category: PSYCHIATRY
10/01/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $48.93 General
Category: Neuroscience
09/20/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $23.76 General
Category: CNS Stimulant for ADHD
08/30/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $24.99 General
Category: PSYCHIATRY
08/22/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.36 General
Category: PSYCHIATRY
08/17/2024 Lundbeck LLC ABILIFY ASIMTUFII (Drug) Food and Beverage Cash or cash equivalent $28.86 General
Category: PSYCHIATRY
08/09/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $2.00 General
Category: PSYCHIATRY
08/08/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $14.31 General
Category: PSYCHIATRY
08/02/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $16.58 General
Category: CNS Stimulant for ADHD
07/24/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $122.51 General
Category: Neuroscience
07/19/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $9.51 General
Category: Neuroscience
06/13/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $14.02 General
Category: PSYCHIATRY
06/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $25.04 General
Category: NEUROSCIENCE
05/23/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $28.01 General
Category: PSYCHIATRY
05/02/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $28.64 General
Category: PSYCHIATRY
04/10/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $28.51 General
Category: PSYCHIATRY
03/28/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.33 General
Category: NEUROSCIENCE
03/19/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $28.70 General
Category: PSYCHIATRY
03/15/2024 Lundbeck LLC ABILIFY ASIMTUFII (Drug) Food and Beverage Cash or cash equivalent $17.55 General
Category: PSYCHIATRY
03/01/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $26.95 General
Category: PSYCHIATRY
02/02/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $24.00 General
Category: CNS Stimulant for ADHD

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 284 829 $129,207 $39,355
2022 3 378 878 $131,829 $40,815
2021 2 273 716 $115,008 $35,974
2020 2 31 69 $6,255 $3,742
Total Patients
966
Total Services
2,492
Medicare Billing
$119,885
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 210 714 $119,952 $35,884 29.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 36 54 $9,072 $3,291 36.3%
36415 Insertion of needle into vein for collection of blood sample Office 2023 38 61 $183.00 $179.34 98.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 228 684 $114,912 $31,424 27.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 90 99 $16,632 $9,110 54.8%
36415 Insertion of needle into vein for collection of blood sample Office 2022 60 95 $285.00 $281.01 98.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 254 684 $114,912 $35,878 31.2%
36415 Insertion of needle into vein for collection of blood sample Office 2021 19 32 $96.00 $96.00 100.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 19 40 $3,320 $2,010 60.5%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 12 29 $2,935 $1,732 59.0%

About Douglas Reed, FNP-C

Douglas Reed, FNP-C is a Psychiatric/Mental Health healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2011. The National Provider Identifier (NPI) number assigned to this provider is 1457641300.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Douglas Reed, FNP-C has received a total of $1,254 in payments from pharmaceutical and medical device companies, with $725.60 received in 2024. These payments were reported across 42 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,154).

As a Medicare-enrolled provider, Reed has provided services to 966 Medicare beneficiaries, totaling 2,492 services with total Medicare billing of $119,885. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Bronx, NY
  • Active Since 04/12/2011
  • Last Updated 12/24/2020
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1457641300

Products in Payments

  • INVEGA SUSTENNA (Drug) $280.94
  • Azstarys (Drug) $205.15
  • ABILIFY ASIMTUFII (Drug) $203.32
  • ABILIFY MAINTENA (Drug) $157.82
  • INGREZZA (Drug) $144.87
  • SPRAVATO (Drug) $117.18
  • VRAYLAR (Drug) $69.23
  • CAPLYTA (Drug) $40.92
  • REXULTI (Drug) $34.86

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Bronx